Sarkomy Kostej Magkih Tkanej i Opuholi Kozi

dragon

Sarkomy Kostej Magkih Tkanej i Opuholi Kozi

Scopus Index (2025)

Sarkomy Kostej Magkih Tkanej i Opuholi Kozi

Sarkomy Kostej Magkih Tkanej i Opuholi Kozi (ISSN:2219-4614 )(E-ISSN:2782-3687) is a monthly peer-reviewed scopus-indexed journal from 2001 to present. The publisher of this journal is ABV-press Publishing house. Sarkomy Kostej, Magkih Tkanej i Opuholi Kozi committed to gathering and disseminating excellent research achievements. The journal welcomes all types of General Medicine journal includes Oncology , Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Orthopedics and Sports Medicine etc.

Aim And Scopes

Sarkomy Kostej Magkih Tkanej i Opuholi Kozi

General Medicine
Oncology
Pathology
Forensic Medicine
Radiology
Nuclear Medicine and Imaging
Orthopedics
Sports Medicine
Latest Journal Here
Sarkomy Kostej Magkih Tkanej i Opuholi Kozi
SKMTOK-04-03-2025-3145 Sarkomy Kostej Magkih Tkanej i Opuholi Kozi
The reconstructive stage in the combined treatment of tumors of bones, soft tissues and skin

Currently, a personalized approach is considered a priority in the treatment of malignant neoplasms of bones, skin and soft tissues. The decision on the treatment plan is formed by a multidisciplinary team of specialists: a surgeon, a chemotherapist, a radiotherapist. The active introduction of systemic therapy and new technologies in radiation therapy made it possible to ensure local and systemic control of the disease, which contributed to the expansion of indications for performing organ-preserving surgical interventions. In order to improve functional results, while observing the radica

Read More
SKMTOK-04-03-2025-3144 Sarkomy Kostej Magkih Tkanej i Opuholi Kozi
Prevalence and prognostic mutation v600e in the braf gene in stage I cutaneous melanoma

Melanoma is one of the most aggressive skin tumors, which occurs against the background of malignant transformation and proliferation of melanocytes. Risk factors for the development of cutaneous melanoma are solar radiation and duration of exposure, old age, individual patient characteristics (light skin, a large number of nevi, including atypical ones, family history) and others. Research in recent years shows that this disease is associated with a number of genetic changes, both congenital and acquired. To study the frequency of occurrence and prognostic significance of the V600E mutatio

Read More
SKMTOK-04-03-2025-3143 Sarkomy Kostej Magkih Tkanej i Opuholi Kozi
Effectiveness of titanium mesh in performing oncological endoprosthesis in patients with tumor lesion of the proximal tibia

Oncologic endoprosthesis of the knee joint in patients with tumors of the proximal calf requires reconstruction of the joint and surrounding structures including the extensor mechanism. This study is based on our experience of using titanium meshes as additional fixation aids for attachment of the patellar ligament to the endoprosthesis. We have developed a technique of extensor mechanism reconstruction and performed comprehensive assessment of the results of its clinical use. To evaluate the effectiveness of using titanium meshes for reconstruction of the knee extensor mechanism during pri

Read More
SKMTOK-04-03-2025-3142 Sarkomy Kostej Magkih Tkanej i Opuholi Kozi
Artificial intelligence in personalized selection of surgical treatment tactics for bone metastases

Selection of surgical treatment tactics for patients with bone metastases is one of the important problems of modern oncology. In the majority of patients with metastatic bone lesions, surgical interventions are aimed at palliative treatment; however, in some cases of solitary metastases, radical resections with a reconstructive component can be performed. Lifespan prognosis associated with histological structure of malignant tumor is the main and crucial factor in determination of suitable type of surgical treatment. To create software for selection of surgical tactics treatment in patient

Read More
SKMTOK-04-03-2025-3141 Sarkomy Kostej Magkih Tkanej i Opuholi Kozi
Omics technologies in diagnosis and treatment of soft tissue sarcomas

Currently, stratification of recurrence risk and prognosis of 5-year survival of patients with soft tissue sarcomas are primarily based on histological tumor classification. Drawing from these data, international oncological societies have proposed a hypothesis about development of gene expression profiling and molecular and genetic diagnosis technologies which will allow to more accurately assess risks of soft tissue sarcoma development and select individual drug treatment.

Read More